Loading clinical trials...
Loading clinical trials...
A Multicenter, Double-Blind, Extension Trial of Two Parallel Dose Groups of Plant Cell Expressed Recombinant Human Glucocerebrosidase (prGCD) in Patients With Gaucher Disease
Conditions
Interventions
Taliglucerase alfa
Locations
11
United States
Department of Human Genetics, Emory University School of Medicine
Decatur, Georgia, United States
Neurogenetics, NYU at Rivergate
New York, New York, United States
Bone Marrow Transplant Service, The Royal Melbourne Hospital
Parkville, Victoria, Australia
Mount Sinai Hospital
Toronto, Ontario, Canada
Pontificia Universidad Catolica de Chile
Santiago, Chile
Rambam Medical Center
Haifa, Israel
Start Date
June 1, 2008
Primary Completion Date
May 1, 2012
Completion Date
August 1, 2013
Last Updated
October 4, 2018
NCT07223944
NCT05992532
NCT03333200
NCT06573723
NCT05487599
NCT03190837
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions